https://www.selleckchem.com/products/GDC-0449.html
Background Rate of corrective nasal surgery after maxillomandibular advancement (MMA) for obstructive sleep apnea (OSA) has been reported to be 18.7% for functional and aesthetic indications. Objective Describe a comprehensive strategy to optimize nasal outcomes with MMA for OSA. Methods A retrospective review of patients undergoing MMA for OSA in a tertiary referral center was performed, with a comprehensive perioperative intervention to optimize nasal outcomes from January 2014 to February 2018. Outcomes included the Apnea-Hypopnea I
Like
Comment
Share
